STUDY OF PENTRAXIN-3 LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AMONG EGYPTIAN PATIENTS

STUDY OF PENTRAXIN-3 LEVELS IN EGYPTIAN CIRRHOTIC PATIENTS

Study of Serum Pentraxin-3 Level in Non-alcoholic Fatty Liver Disease and Its Affection by Concomitant Chronic Hepatitis B Virus Infection in Egyptian Patients

Serum Pentraxin 3 as a Biomarker of Hepatocellular Carcinoma in Egyptian Liver Cirrhotic Patients

Association between serum level of pentraxin-3 and interleukin-40 with HCC disease in Egypt

Diagnostic performance of serum steatosis biomarkers in Prediction of Non Alcoholic Fatty Liver Disease in Adult Asymptomatic Egyptians

A study of the Role of 25 Hydroxy-Cholecalciferol Level on Non Alcoholic Fatty Liver Disease (NAFLD) in a Cohort of Egyptian Patients

SERUM MARKERS FOR ASSESSING LIVER FIBROSIS IN EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B AND C CO-INFECTION VERSUS CHRONIC HEPATITIS C

Serum soluble cluster of differentiation 163 (sCD163), matrix metalloproteinase 9 (MMP9) and cytokeratin 18 (CK18) levels as biomarkers for liver fibrosis in Egyptian chronic hep

ASSESSMENT OF LIVER STIFFNESS IN NONALCOHOLIC FATTY LIVER DISEASE